In Trial 1, 26 heifers were allotted randomly to a control group or one of four groups to receive a single injection of 3,000 IU hCG on d 1, 4, 7 or 10 of an estrous cycle. Heifers next completed a nontreated cycle, and at their third estrus were reallotted to one of the five groups described previously. Estrous cycle length was extended in cycle 1 but was not altered during the nontreated cycle or in cycle 3. Administration of hCG on d 4 or 7 increased (P < .05) mean serum progesterone (P4) over the first 16 d of the estrous cycle by .9 and .8 ng/ml, respectively. In Trial 2, 23 heifers were allotted randomly to one of two groups to receive a placebo or a single injection of 3,000 IU hCG on d 4 of an estrous cycle. Heifers were inseminated artificially at subsequent estrus. On d 4 postbreeding, treatments were repeated. Administration of hCG on d 4 of the prebreeding estrous cycle increased (P < .05) mean P4 over the first 16 d by .9 ng/ml, whereas mean P4 over the first 16 d postbreeding was not affected by a second injection of hCG on d 4 postbreeding. Administration of hCG increased (P < .05) first-service pregnancy rate (92 vs 55%). In conclusion, progesterone concentrations were enhanced by hCG given on d 4 or 7 of the estrous cycle, and pregnancy rate was increased when hCG was administered both on d 4 of the prebreeding cycle and d 4 postmating.
pregnancy maintenance. Additionally, P4 concentration during the prebreeding estrous cycle also may be involved in pregnancy maintenance (Folman et al., 1973; Corah et al., 1974; Erb et al., 1976; Fonseca et al., 1983) .
Exogenous hCG increases P4 synthesis (Mason et al., 1962; Veenhuizen et al., 1972; Eduvie and Seguin, 1982; Helmet and Britt, 1986, 1987; Shipley et al., 1988) . Administration of hCG postbreeding has been reported to increase (Brown et al., 1973) or have no effect (Hansel et al., 1976; Echtemkamp and Maurer, 1983) on pregnancy rate. Effects of hCG administration prebreeding on pregnancy rate also have been inconclusive (Helmer and Britt, 1986) . Our objectives were 1) to determine optimal time during the estrous cycle to administer hCG to increase systemic P4 concentration and 2) to determine effects of hCG both during the prebreeding estrous cycle and postbreeding on systemic P4 concentration and pregnancy rate.
Me.rials and Methods
Trial 1. Thirty crossbred heifers received an initial injection of 30 mg Lutalyse| 3 followed by a second injection of 30 mg Lutalyse| 11 d later to synchronize estrus. Following the second Lutalyse| injection, heifers were observed for estrus twice daily for 30 min throughout three consecutive estrous cycles. Androgenized cows fitted with chin-ball markers aided in detection of estrus. Twenty-six heifers exhibited estrus and were allotted randomly to a nontreated control group or one of four groups receiving a single i.m. injection of 3,000 IU hCG on d 1, 4, 7 or 10 of an estrous cycle (estrus = d 1). Heifers continued on the experiment through a nontreated estrous cycle and, as they exhibited their third estrus, heifers were stratified by cycle 1 treatment group, reallotted to one of the five groups and received the treatments outlined previously. Blood samples were collected from each heifer via jugular venipuncture at 24-h intervals during the treated estrous cycles (1 and 3) and at 48-h intervals during the nontreated estrous cycle (2).
Trial 2. Ninety days following Trial 1, the same 30 heifers again received two injections of Lutalyse| 11 d apart and 23 were observed in estrus. Results from Trial 1 suggested that administration of a single injection of 3,000 IU hC~ on d 4 of an estrous cycle consistently increased P4 concentration; therefore, d 4 was selected as the treatment day for Trial 2. As heifers exhibited estrus, they were allotted randomly to one of two treatment groups. On d 4 of the prebreeding estrous cycle, heifers in treatment group 1 received a placebo injection of 3 ml .9% benzyl alcohol (the hCG vehicle), and heifers in treatment group 2 received a single i.m. injection of 3,000 IU hCG. As heifers returned to estrus, they were inseminated artificially 12 h following estrus by one technician. On d 4 postbreeding, heifers in treatment group 1 again received 3 ml of the placebo, and heifers in treatment group 2 received a single injection of 3,000 IU hCG. Blood Collection and Progesterone Assay.
In both trials, whole blood stored on ice immediately after collection, was transferred and stored at 4~ for 12 to 15 h before separation of serum. Progesterone was measured in a direct RIA (Breuel et al., 1988) using a highly specific antiserum (GDN 337) 4. Intraassay coefficients of variation were 17, 9 and 8% for a low, medium and high lx~ol, respectively, measured in duplicate in 52 assays. Interassay coefficients of variation were 19, 10 and 9% for the same pools measured in duplicate in 52 assays. Sensitivity of the assay was .4 ng/ml.
Statistical Analysis.
Trial 1. The experiment was arranged in a completely random design. For estrous cycle length, analysis of variance was done for each cycle separately. Estrous cycle mean and daily P4 concentrations were analyzed as a repeated measures design over the three cycles. For daily P4 concentrations, those measurements on heifers made prior to their treatment were grouped with the control treatments in order to increase precision of estimates of control means. Data from estrous cycle 2 (the nontreated cycle) also were grouped with control data after it was shown that there were no carry-over effects of hCG trealment. Preplanned comparisons among treatment least squares means were tested using Student's ttests (Steel and Torde, 1980) . Trial 2. This experiment also was arranged and analyzed as a completely random repeated measures design for estrous cycle length, mean P4 and dally P4 concentrations. Limited comparisons were made between treatment least square means and differences were tested using Student's t-tests (Steel and Torrie, 1980) . Pregnancy data were analyzed by general least squares means analysis of discrete data in a completely randomized design (Harvey, 1982) . Preplanned comparisons were made between least squares means and differences were tested using Student's t-tests (Steel and Tonic, 1980) . "Mean • SE. b~leans in same column with superscripts different from control differ (P < .05).
Ra~I~
Trial 1. In estrous cycle 1, a single i.m.
injection of hCG on d 1, 4, 7 or 10 extended (P < .05) estrous cycle length by 2.8, 4.6, 6.3 and 4.8 d, respectively, over that of control heifers (Table 1 ). In cycle 2 (nontreated), no differences were detected in estrous cycle length between groups previously assigned to ~eatments in cycle 1. In contrast to cycle 1, estrous cycle length in cycle 3 was not affected by hCG administration irrespective of treatment day (Table 1) .
To compensate for differences in cycle length, hormonal data were normalized to the day of estrus (d 1) and daily means for the first 16 d were plotted, followed by the 5 d to and including next estrus for each estrous cycle. There were no differences in either daily or cycle mean P4 concentration between the two hCG treated cycles (1 and 3); therefore, data from these cycles were combined.
Administration of a single i.m. injection of hCG to heifers on d 4 or 7 of the estrous cycle increased cycle mean P4 over the first 16 d by .9 and .8 ng/ml, respectively, compared with heifers in the control group (P < .05; Table 2 ).
In contrast, mean P4 concentration over the first 16 d was not affected when hCG was administered to heifers on d 1 or 10 of the estrous cycle. Mean P4 over the last 5 d of the estrous cycle was 1.3 ng/ml lower in heifers administered hCG on d 7 (P < .05) compared with the control group. Treamaent effects observed in cycle 1 had no carry-over effect on mean P4 concentration during the first 16 or last 5 d of the nontreated estrous cycle.
A single i.m. injection of hCG on d 1 of the estrous cycle had no effect on daily P4 concentration over the first 16 d (Figure 1) . However, administration of hCG on d 4 of the estrous cycle increased (P < .05) P4 concentrations by 1.2, 1.8, 2.9, 2.2 and 3.1 ng/ml on d 9, 11, 13, 15 and 16, respectively. Likewise, administration of hCG on d 7 of the estrous cycle increased (P < .05) P4 by 2.2, 2.0, 2.3, 3.2 and 3.4 ng/ml on d 12 through 16, respectively. Finally, administration of hCG on d 10 of the estrous cycle increased (P < .05) P4 2.6, 2.1 and 3.3 ng/ml on d 13, 15 and 16, respectively.
During the first 16 d of the nontreated estrous cycle no differences were found in daily P4 concentration when comparisons were made among groups assigned to previous ueatment groups in cycle 1 (Figure 2) .
Trial 2. Treatment with hCG on d 4 of the prebreeding estrous cycle extended cycle length beyond that of control heifers (20.8 vs 19.4 d). As in Trial 1, hormonal data were normalized to allow for differences in cycle length between treatments. Dally mean P4 concentration over the first 16 d of the prebreeding estrous cycle was greater (P < .05) in hCG-treated heifers than in control heifers (Table 3) .
Administration of hCG on d 4 of the prebreeding esU'ous cycle increased (P < .05) daily P4 by 1.6, 1.3, 1.4, 1.6, 1.8 and 2.0 ng/ml on d 8, 9, 12, 13, 15 and 16, respectively (Figure 3) . Administration of hCG on d 4 postbreeding (consecutive cycle) had no effect on mean (Table 3) or daily I'4 concentration over the first 16 d postbreeding.
Adminismuiun of hCG on d 4 of both the prebreeding cycle and postbreeding increased (P < .05) first-service pregnancy rate (11/12 vs 6/11 heifers). Because only one animal in the hCG-treated group failed to maintain pregnancy, limited comparisons could be drawn between ueatment groups for P4 concentrations pre-and post-breeding.
Mean P4 during the prebreeding eslIous cycle was not different over the first 16 d (2.4 + .4 vs 2.6 :t: .4 ng/ml) or last 5 d (1.2 + .5 vs 1.4 + .5 nghnl) between control heifers subsequently diagnosed nonpregnant or pregnant, respectively. Similarly, mean P4 was not different over the first 16 d (2.9 5:.4 vs 3.0 + .2) and last 5 d (1.5 + .5 vs 1.7 + .3) of the prebreeding estrous cycle between treated heifers subsequently diagnosed as nonpregnant or pregnant.
In pregnant heifers, no difference was found in mean P4 during the prebreeding estrous cycle over the first 16 d (2.6 + .4 vs 3.5 + .3 ng/ml) or last 5 d (1.4 + .5 vs 2.0 + .4 ng/ml) between control and hCG-treated heifers, respectively. However, heifers administered hCG and subsequently diagnosed as pregnant had greater concentrations of 1'4 on d 8 of the prebreeding esm~us cycle than did pregnant control heifers (P < .05; Figure 4) . Mean P4 over the first 16 d postbreeding was similar (2.5 + .4 vs 2.2 + .3 ng/ml) between control heifers subsequently diagnosed as nonpregnant or pregnant. Likewise, no difference was found in mean P4 over the first 16 d postbreeding between treated heifers subsequently diagnosed as nonpregnant or pregnant (2.3 + .2 vs 2.6 + .3 ng/ml). Mean P4 over the first 16 d postbreeding was similar (2.2 + .3 vs 2.5 + .2 ng/ml) between control and hCGqreated heifers subsequently diagnosed as pregnant. ment. However, beginning on d 17, I'4 concentration was greater (P < .05) in pregnant than in nonpregnant heifers ( Figure 6 ). Daily P4 concentrations over the first 16 d postbreeding were similar between control and hCG-Ireated heifers subsequently diagnosed as pregnant.
~IMCtlJOn Human chorionic gonadotropin exhibits luteotropic properties by extending functional lifespan of bovine corpora lutea (Wilthank et al.. 1961) and by increasing endogenous P4 synthesis from the bovine corpus luteum (Veenhuizen et al., 1972; Seguin et al., 1977; Helmer and Britt, 1986, 1987) . Eduvie and Seguin (1982) observed extended estrous cycle length in heifers administered four injections of 10,000 IU of hCG at 7-d intervals or two injections at 14-d intervals. Additionally, administration of a single injection of 10,000 IU hCG on d 10 or 15 extended estrous cycle length, whereas administration on d 17 failed to alter cycle length (Seguin et al., 1977) . In the present study, success and then failure of repetitive hCG adminisumions to extend functional lifespan of the corpus luteum might be attributed to antibody formation against hCG. However, results obtained in cycle 3 of Trial 1, in which P4 concentrations were increased following a repetitive hCG administration, do not support this hypothesis. Additionally, Eduvie and Seguin (1982) found no evidence of anti-hCG antibody formation 2 wk following administration of four injections of 10,000 8" Limited data are available concerning effects of hC"G administrmion during single or consecutive estrous cycles on systemic P4 concentration. Findings in Trial 1 suggest that administration of a single i.m. injection of 3,000 IU hCG to heifers on d 4 or 7 of the estrous cycle effectively increases systemic I)4 concentxation. This effect appears to he dependent on functional capacity of the bovine corpus luteum, because administration of hCG during periods of early (d 1) or late luteal (d 10) phase were less effective in increasing P4 concentration. These findings support those of Morris et ai. (1976) , who reported that administration of 1,500 IU hOG at the time of insemination failed to increase 1)4 concentration on d 9 or 16.
In Trial 1, luteotropic effects observed in cycle 1 attributed to hOG administration failed to elicit any carry-over effects into the nontreateM cycle. Similarly, Veenhuizen et al. (1972) found no residual effect of hOG adminismition during one estxous cycle on corpora lutea formed during subsequent cycles. Results from Trial 1 suggested that the optimal time (or time range) during the estrous cycle to administer a single i.m. injection of 3,000 IU hCG that would increase systemic 1)4 concentrations was d 4 or 7.
In Trial 2, results obtained in the prebre,~-ing estrous cycle confirmed findings in Trial 1 that administration of a single injection of 3,000 IU hCG on d 4 of the estxous cycle increased systemic P4 concentrations. Administration of a second injection of 3,000 IU hCG on d 4 postbreeding failed to elicit an effect on systemic 1)4 concentrations. Nevertheless, firstservice pregnancy rate was greater in heifers administered a single injection of 3,000 IU hOG on d 4 of both the prebreeding estrous cycle and postbreeding than in control heifers. These findings are in contrast to those of Wagner et al. (1973) , Hansel et al. (1976) and Echternkamp and Maurer (1983) , who reported that administration of 1,000 to 1,500 IU hCG at the time of breeding had no effect on firstservice pregnancy rate. These data, combined with ours, suggest that the luteal cell is not competent to respond to hOG on d 1, but that it can respond on d 4.
Discrepancies concerning P4 concentration in pregnant, compared with nonpregnant, cows and heifers are numerous. Shemesh et al. (1968) reported similar plasma 1)4 concentra- tions during d 10 to 18 after ovulation in cycling and inseminated cows whether the latter were pregnant or not. Our results in Trial 2 support those observations. In contrast, Henricks et al. (1972) reported greater P4 concentrations in pregnant heifers as early as d 9 postbreeding compared with nonpregnant heifers. Results from Trial 2 further suggest no difference in P4 concentration between nonpregnant and pregnant heifers during the prebreeding estrous cycle. Likewise, no differc~ce was observed during the prebreeding estrous cycle between control heifers subsequently diagnosed as nonpregnant or pregnant. These findings are in contrast to those of Folman et al. (1973) , who reported greater P4 concentrations between d 4 through d 15 of the prebreeding estrous cycle in cows that subsequently were diagnosed as pregnant compared with those that were not pregnant. Findings in the present study also conflict with those of Corah et al. (1974) , who reported greater P4 concentrations immediately preceding the estrus associated with pregnancy in heifers.
Results from the present study indicate that hCG is luteolaopic when administered during the esu'ous cycle in the bovine species.
However, the effect of repetitive administration during consecutive estrous cycles is vaguely understood. Additionally, ability of hCG to promote P4 synthesis appears to be dependent largely on the functional state of the bovine corpus luteum, as indicated by differences in response to administration of hCG at different times during the estrous cycle.
